BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Wu N. MicroRNAs and Exosomal microRNAs May Be Possible Targets to Investigate in Gestational Diabetes Mellitus. Diabetes Metab Syndr Obes 2022;15:321-30. [PMID: 35140490 DOI: 10.2147/DMSO.S330323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Bernea EG, Suica VI, Uyy E, Cerveanu-hogas A, Boteanu RM, Ivan L, Ceausu I, Mihai DA, Ionescu-tîrgoviște C, Antohe F. Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus. Molecules 2022;27:5502. [DOI: 10.3390/molecules27175502] [Reference Citation Analysis]
2 Gao Z, Wang N, Liu X. Human placenta mesenchymal stem cell-derived exosome shuttling microRNA-130b-3p from gestational diabetes mellitus patients targets ICAM-1 and perturbs human umbilical vein endothelial cell angiogenesis. Acta Diabetol 2022;59:1091-107. [PMID: 35676597 DOI: 10.1007/s00592-022-01910-2] [Reference Citation Analysis]
3 Jafari N, Llevenes P, Denis GV. Exosomes as novel biomarkers in metabolic disease and obesity-related cancers. Nat Rev Endocrinol 2022. [PMID: 35361917 DOI: 10.1038/s41574-022-00666-7] [Reference Citation Analysis]